BioSpace News Archive

Option Care Health Inc. announced that John Rademacher, Chief Executive Officer, will participate in a fireside chat on September 10 at the Morgan Stanley Global Healthcare Conference, scheduled to start at 10:00 a.m. EDT.

BIOREM Inc. announced its results for the three and six-month periods ended June 30, 2019.

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present a company overview at the Wells Fargo Healthcare Conference in Boston on Thursday, September 5, 2019.

BIOASIS TECHNOLOGIES INC. announced that it has granted stock options to acquire a total of 875,000 common shares at a price of $0.32 per share to directors of the company.

Reckitt Benckiser LLC (RB), a global leader in consumer health, hygiene and home, announces the debut of VEO Active-Probiotics Surface Cleaner, a revolutionary line that harnesses the power of probiotics

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will be attending the following upcoming investor conferences:

LabCorp® announced it will participate at the Morgan Stanley Global Healthcare Conference.

FairWarning, a global privacy company providing solutions that protect data in electronic health records (EHRs), Salesforce and hundreds of other cloud-based applications, today announced the appointment of Ed Holmes as Chief Executive Officer

Ravon Ortiz and Wardell Starling are the latest patients to emerge from vegetative states in Nexus Health Systems’ program, The Phoenix Project.

The World Health Organization (WHO) recently posted a report showing the effectiveness of spatial repellents in fighting malaria.